Professor Prevost along with co-authors has been published in BMC Medicine. The study is titled:
Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial.
The study consisted of a single-centre Phase III fast-track single-blind mixed-method RCT comparing the Breathlessness Intervention Service (BIS) with standard care. The study concluded that ‘BIS appears to be more effective and cost-effective in advanced cancer than standard care’.